Positive Airway Pressure Devices market to Eyewitness Huge Marginal Growth by 2027

 


The global positive airway pressure devices market size is anticipated to reach USD 2.7 billion by 2025, expanding at a CAGR of 7.0%, according to a new report by Grand View Research, Inc. An increase in the patient pool suffering from Obstructive Sleep Apnea (OSA) is one of the key factors anticipated to drive the market growth. Furthermore, an increase in the compliance rate of positive airways pressure (PAP) machines due to growing awareness for sleep apnea and its associated disorders is likely to drive growth over the forecast period. However, the availability of alternative treatment options such as nasal surgery, uvulopalatopharyngoplasty (UPPP), and mandibular maxillomandibular advancement surgery and the on-going clinical trials for the development of sleep apnea medications are some of the major challenges to the market growth.

In 2018, the CPAP device dominated the market, with a revenue of USD 1.3 billion. The penetration of CPAP is increasing owing to improved patient outcomes and favorable reimbursement policies across various countries. Moreover, the launch of portable travel-friendly CPAP machines has also influenced the growth of this segment. On the other hand, the BiPAP device is expected to exhibit the fastest growth rate over the forecast period, owing to its higher efficiency compared to other PAP devices.

North America dominated the market in 2018, with a revenue share of 47.4%, owing to the presence of a large patient pool in the region. Furthermore, the presence of major players and increasing awareness related to OSA and its consequences are some of the secondary factors driving the growth in this region. Moreover, the region is anticipated to grow at the fastest rate over the forecast period, due to high healthcare expenditure and availability of medical insurance coverage in the region.

According to a study conducted by the American Academy of Sleep Medicine (AASM) in 2016, the annual economic burden caused due to undiagnosed sleep apnea among U.S. adults was approximately USD 149.6 billion. Whereas, treated sleep apnea would result in an annual economic savings of over USD 100 billion in the country. Due to this, the government institutions across various regions have started focusing on increasing the overall treatment rate by creating awareness among citizens on obstructive sleep apnea and its treatment, thus, boosting the demand for positive airways pressure (PAP) machines globally.

Have a Query? Ask Our Expert:

https://www.grandviewresearch.com/inquiry/6864/ibb

The market is oligopolistic and is consolidated with limited number of companies operating in this space. Some of the players operating in this market include Koninklijke Philips N.V. (Philips Respironics); Curative Medical; ResMed; Fisher and Paykel Healthcare Limited; Drive DeVilbiss Healthcare Inc.; and Somnetics International, Inc. These companies are focused on new product development, strategic acquisitions, and developing partnerships to gain higher market share. Moreover, strong geographic presence in multiple countries, a wide product portfolio, and a large number of distributors has helped the key players to strengthen their market presence.

Further key findings from the report suggest:

  • The global PAP Devices market is anticipated to be USD 2.7 billion by 2025, owing to the high prevalence of OSA
  • CPAP devices accounted for a major share in 2018 with a revenue of USD 1.3 billion, owing to the increasing awareness about sleep apnea related treatments among patients
  • North America dominated the market in 2018, owing to the availability of favorable reimbursement policies for PAP devices in the region
  • Some of the key players are Koninklijke Philips N.V. (Philips Respironics); Curative Medical; ResMed; Fisher and Paykel Healthcare Limited; and Drive DeVilbiss Healthcare, Inc. 

Grand View Research has segmented the global PAP devices market based on product type:

PAP Devices Product Type Outlook (Revenue, USD Million, 2014 - 2025)

  • CPAP
  • APAP
  • BiPAP

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

 

 

Comments

Popular posts from this blog

Vertical Farming Market Growth On The Basis Of Type, Application, Region & Forecast To 2030: Grand View Research Inc.

Clinical Diagnostics Market Segment Analysis By Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

Satellite Payload Market Growth On The Basis Of Type, Application, Region & Forecast To 2025: Grand View Research Inc.